December 19, 2023
MicrofluidX secures £1m funding via Innovate UK Investor Partnerships Future Economy programme, supported by Longwall Ventures. Stevenage, UK– MicrofluidX (MFX), a UK-based developer of technologies that streamline the development and deployment of cell and gene therapies, is delighted to announce that it has been awarded £685,000 in funding from Innovate UK via their Investor Partnership [...]
Waters Earns Sustainability Designation from My Green Lab for Xevo TQ Absolute System
December 19, 2023
News Summary: My Green Lab awards ACT label to the Waters Xevo™ TQ Absolute system, providing independent validation for its sustainable manufacturing, packaging operation, and end-of-life. Laboratory instruments that earn the ACT label make it easy for scientists and procurement professionals to choose more sustainable products. Xevo TQ Absolute system is up to 45% smaller, [...]
December 19, 2023
Novel GHz-class NMR systems are enabling unprecedented life science and materials research in functional structural biology, drug discovery, metabolomics and cleantech research. COLUMBUS, Ohio -- Bruker Corporation, the leading provider of nuclear magnetic resonance (NMR) spectroscopy solutions for life and materials research, today announced the successful installation of a 1.2 Gigahertz (GHz) NMR system at [...]
December 19, 2023
WATERTOWN, Mass. — Fluent BioSciences, a leader in breakthrough single-cell analysis technology, and Element Biosciences, a pioneer in novel sequencing solutions, are excited to announce their collaboration to enhance the accessibility and scalability of single-cell RNA sequencing (scRNA-seq). Single-cell RNA sequencing has been a crucial tool in unraveling cellular and molecular diversity within complex tissues. [...]
December 19, 2023
CellAssist Software Release 5.0 provides advanced capabilities to accurately count cells and measure their confluence using quantitative phase imaging (QPI) and proprietary algorithms BOSTON -- Thrive Bioscience Inc., a provider of innovative automated live cell imaging instruments and software, debuted its CellAssist Software Release 5.0, a new integrated suite of advanced live cell imaging capabilities [...]
Spectaire Launches AireCore™ Into the Oil and Gas Sector
December 18, 2023
Mass Spectrometry now available to be used in the Broad Set of the Oil and Gas Industry’s Operational Challenges WATERTOWN, Mass. -- Spectaire Holdings Inc. (NASDAQ: SPEC), a leader in air quality monitoring and emissions reduction technology, has completed the innovation in its mass spectrometer series to open up the Oil and Gas industry to [...]
Coloured 96-well skirted PCR plates
December 18, 2023
Azenta Life Sciences popular FrameStar® 96-well Skirted PCR plate is now available in a wide range of colours (purple, blue, clear, green, red, black, and white) to enable easy visual identification in multi-user labs. whether you work in a busy pathology, molecular diagnostics, or academic lab, assigning different coloured PCR plates can be a real gain. Being able to assign [...]
December 18, 2023
Miltenyi Biotec to supply scalable, GMP-compliant, PRAME-targeted TCR-NK cell therapy product using the CliniMACS Prodigy® system for clinical development and future commercial supply Syena secures exclusive license to Miltenyi Biotec’s PRAME TCR Syena, co-founded by Replay and MD Anderson in 2023, will develop an off-the-shelf PRAME TCR-NK cell therapy, with IND anticipated Q1 2024 Bergisch [...]
December 18, 2023
NORTH BRUNSWICK, N.J. — TheWell Bioscience, a pioneer of 3D biomimicking platforms for precision medicine, cell therapy, and biomanufacturing, announces the launch of VitroGel®-Based Cell Invasion Assay Kits. Using the xeno-free VitroGel® hydrogels, these new kits revolutionize how researchers study cell migration and invasion, offering unprecedented accuracy, efficiency, and reliability for cell migration assays. The VitroGel-Based Cell [...]
Illumina Announces Decision to Divest GRAIL
December 17, 2023
SAN DIEGO -- Today, Illumina, Inc. (NASDAQ: ILMN) announced that the company will divest GRAIL. The divestiture will be executed through a third-party sale or capital markets transaction, consistent with the European Commission's divestiture order, with the goal of finalizing the terms by the end of the second quarter of 2024. On December 15, the U.S. [...]

